formoline L112

formoline L112
Product Description

Formoline L112 is a clinically proven medical device that supports weight management through its fat-binding mechanism. The active ingredient, polyglucosamine L112 from crustacean sources, binds dietary fats in the stomach and reduces their absorption in the small intestine. This lowers calorie intake and contributes to both weight reduction and long-term weight control.

Beyond weight management, studies show that polyglucosamine L112 can help reduce cholesterol levels and support cardiovascular health. The product is intended for adults with a BMI above 27, to be used alongside a balanced diet and regular physical activity.

Formoline L112 is available in tablet form and is easy to integrate into daily routines. It is not recommended for children, underweight individuals, pregnant or breastfeeding women, or those with severe gastrointestinal disorders or crustacean allergies.

Read more Show less

Certmedica International GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
OTC
Other
Pharmaceutical company
Primary activities
Cosmeceuticals
OTC
Pharmaceutical Company (innovator finished products)
Pharmacy
View company profile
Categories
more categories Show less
Specifications
  • Details
    Specification – Formoline L112 
    • Active ingredient: Polyglucosamine L112 (derived from crustacean shells)
    • Mode of action: Binds dietary fats in the stomach → reduces fat absorption in the small intestine
    • Primary effects: Lower calorie intake, weight reduction, weight maintenance, cholesterol reduction
    • Formulation: Tablet form
    • Dosage: 2 tablets before or with the two main high-fat meals per day (total: 4 tablets daily) with at least 250 ml water
    • Composition: ß-1,4-polymer of D-glucosamine and N-acetyl-D-glucosamine

    Application Areas – Formoline L112
    • Target: Adults with BMI ≥ 27
    • Use: Supports weight management, reduces fat absorption, may lower cholesterol and cardiovascular risk
    • Not suitable for: Children < 3 yrs, underweight (BMI <18.5), pregnant/breastfeeding women, crustacean allergy, severe GI disorders
  • Selling Points
    Weight Loss Management
  • Model
    EXTRA
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

Certmedica International GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
OTC
Other
Pharmaceutical company
Primary activities
Cosmeceuticals
OTC
Pharmaceutical Company (innovator finished products)
Pharmacy
View company profile

More Products from Certmedica International GmbH (2)

  • formoline mannan

    Product formoline mannan

    Relaxed weight loss thanks to the satiating effect of the konjac root. 


    Formoline Mannan contains the konjac root from Southeast Asia, a plant that has been valued for centuries in the region as both a food and a traditional remedy. Its water-absorbing properties and the resulting feeling o...
  • formoline protein diet

    Product formoline protein diet

    Formoline Protein Diet is a complete, nutrient-rich meal replacement designed to support weight management. It is made from high-quality protein concentrate, carefully controlled and manufactured in Germany to ensure the highest standards.

    Formoline Protein Diet allows you to replace main meal...